With no further treatment, the 1996 ten-month arthritis follow-up data (n=92) from a high pollen period in Oregon, Washington and Idaho together showed a greater reduction in the active group (n=43) than the placebo group (n=49) on the primary endpoint, defined as a combination of symptom cure and arthritis and rescue medication scores.8 Patients gave blood serum samples prior to the treatment in 1995 and one year later in 1996. They were immunoassayed for specific IgE antibodies cure using a chemi-luminescent technique. Statistician Bradley Rosebrook ran T-Tests comparing average baseline IgE levels to one-year. For the seasonal allergens reported, the active group (n=27) had on average a greater reduction in IgE than arthritis the placebo group (n=34) for 13 out of 16 allergens.8

Studies indicate that ingested oral cyanocobalamin cure tablets are ineffective in the treatment of allergic disease, perhaps because once ingested, they are directly arthritis metabolized in the liver. When B12 is delivered via injection or lozenge it passes throughout the bloodstream before arriving at the liver. It cure is during this first pass arthritis in its cure native form that it is believed to exert its therapeutic effect. CLINICAL RESEARCH: "The World Health Organization (WHO) arthritis recognizes allergic rhinitis (hay fever), sinusitis, cure asthma,...conjunctivitis, urticaria, eczema, dermatitis (contact and arthritis atopic)...allergic and migraine headache...as diseases in which IgE-mediated allergy cure may be involved."1 In 1988, asthma and allergic rhinitis arthritis subjects were treated with B12. Total IgE, specific cure IgE and pulmonary lung functions were taken at days 45, 150 and 180 from baseline. Eight of the 9 subjects had reduced IgE. 2 In 1989 open label studies at two sites in Riverside County, CA in 1989. Sixteen of the 17 subjects had lowered IgE levels from Day 0 to Day 30.3

©2003 www.asian-homeopathic-remedies.com All rights reserved.